Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Calithera Biosciences Inc (CALA)

  7. Calithera Biosciences Inc (CALA) News

CALA

Calithera Biosciences Inc
0.20
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Calithera Biosciences Inc CALA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 0.20 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.20 0.20
more quote information »

Recent News

Date Time Source Heading
3/14/202316:16EDGARTermination of Registration of a Class of Security Under..
3/14/202316:13EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
3/14/202316:03EDGARPost-effective Amendment to Registration Statement (pos Am)
3/03/202310:46EDGARNotification Filed by National Security Exchange to Report..
2/14/202311:49EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202308:04EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202316:02EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202316:06EDGARAmended Statement of Ownership (sc 13g/a)
1/25/202316:01EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:01EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:01EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:01EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202316:01EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202308:08EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
1/09/202308:00GLOBECalithera Biosciences Announces Board Approval of Complete..
12/08/202211:50EDGARAmended Statement of Ownership (sc 13g/a)
11/15/202206:25TRMNH.C. Wainwright Sticks to Its Buy Rating for Calithera Bio..
11/14/202216:17EDGARCurrent Report Filing (8-k)
11/14/202216:05GLOBECalithera Biosciences Reports Third Quarter 2022 Financial..
11/08/202216:30GLOBECalithera Biosciences to Report Third Quarter 2022 Financial..
10/03/202209:34TRMNCalithera Rises on Fast Track Designation for Sapanisertib
10/03/202207:56DJNCalithera Biosciences Gets FDA Fast Track For Lung Cancer..
10/03/202207:00GLOBECalithera Receives FDA Fast Track Designation for..
9/29/202216:03EDGARCurrent Report Filing (8-k)
9/06/202216:05GLOBECalithera to Present at the H.C. Wainwright 24th Annual..
8/16/202217:23EDGARNotification That Quarterly Report Will Be Submitted Late..
8/16/202206:11EDGARQuarterly Report (10-q)
8/15/202217:04EDGARCurrent Report Filing (8-k)
8/15/202216:05GLOBECalithera Biosciences Reports Second Quarter 2022 Financial..
8/08/202216:05GLOBECalithera Biosciences to Report Second Quarter 2022..
7/13/202216:01GLOBECalithera Biosciences Shares Progress in Sapanisertib and..
7/06/202216:01GLOBECalithera Biosciences Announces First Patient Enrolled in..
7/06/202206:19EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202206:13EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/23/202216:05GLOBECalithera Biosciences Announces First Patient Enrolled in..
6/14/202216:31EDGARCurrent Report Filing (8-k)
6/14/202212:50GLOBECalithera Biosciences Announces 1-for-20 Reverse Stock Split
6/03/202216:34EDGARCurrent Report Filing (8-k)
6/03/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202223:39TRMNSVB Securities Thinks Calithera Bio’s Stock is Going to..
5/23/202216:42EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/23/202216:40EDGARCurrent Report Filing (8-k)
5/17/202207:00GLOBECalithera to Present at the H.C. Wainwright Global..
5/12/202205:55TRMNCalithera Bio (CALA) Gets a Hold Rating from Wells Fargo
5/12/202203:31TRMNSVB Securities Remains a Buy on Calithera Bio (CALA)
5/10/202216:08EDGARCurrent Report Filing (8-k)
5/10/202216:05GLOBECalithera Biosciences Reports First Quarter 2022 Financial..
5/03/202216:05GLOBECalithera Biosciences to Report First Quarter 2022 Financial..